
Diamond BioFund is a true example of
“smart- money”
– Nahum Ferera/ CEO & Co Founder –
Diamond BioFund is a true example of “smart- money”. I am very honored to partner with a VC that understand the life-science industry, the changing environment and the multicultural differences. Diamond Biofund is also long lasting partner that was interested in seeing the company growing and succeeding to bring a true value to humankind.
EyeYon Medical is an Israel-based medical device startup that develops innovative medical devices for the treatment of the cornea. EyeYon Medical has developed two therapeutic materials: Hyper-CL and EndoArt. Hyper-CL (High Permeability Contact Lens) is an effective non-surgical treatment for corneal edema. It is made of highly permeable contact lenses. They are disposable contact lenses and need to be replaced every two weeks. The product’s efficacy has been proven through clinical studies, is CE marked and FDA approved, and has been approved for sale in the European and US markets. EndoArt is an artificial retina replacement solution developed by EyeYon Medical that replaces the damaged endothelial layer of the eye with an artificial endothelial layer. The procedure is minimally invasive and seamless, requiring only a very small incision to insert the artificial layer. The product has already obtained the EU CE mark and received FDA approval for human clinical trials.